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Randomized Comparison of FFR-Guided
and Angiography-Guided Provisional
Stenting of True Coronary Bifurcation Lesions
The DKCRUSH-VI Trial (Double Kissing Crush Versus
Provisional Stenting Technique for Treatment of
Coronary Bifurcation Lesions VI)Shao-Liang Chen, MD,*y Fei Ye, MD,* Jun-Jie Zhang, PHD,* Tian Xu, MBBS,z Nai-Liang Tian, MD,z
Zhi-Zhong Liu, PHD,z Song Lin, MD,x Shou-Jie Shan, MD,* Zhen Ge, MD,* Wei You, MD,z Yue-Qiang Liu, MD,x
Xue-Song Qian, MD,k Feng Li, MD,{ Song Yang, MD,# Tak W. Kwan, MD,** Bo Xu, MBBS,yy Gregg W. Stone, MDzzABSTRACTOBJECTIVES This study sought to compare the outcomes of fractional ﬂow reserve (FFR)–guided and angiography
(Angio)–guided provisional side-branch (SB) stenting for true coronary bifurcation lesions.
BACKGROUND Angio-guided provisional SB stenting after stenting of the main vessel provides favorable outcomes for
the majority of coronary bifurcation lesions. Whether an FFR-guided provisional stenting approach is superior has not
been studied.
METHODS A total of 320 patients with single Medina 1,1,1 and 0,1,1 coronary bifurcation lesions undergoing stenting
with a provisional SB approach were randomly assigned 1:1 to Angio-guided and FFR-guided groups. SB stenting was
performed for Thrombolysis In Myocardial Infarction ﬂow grade <3, ostial SB stenosis >70%, or greater than type
A dissection after main vessel stenting in the Angio-guided group and for SB-FFR <0.80 in the FFR-guided group.
The primary endpoint was the 1-year composite rate of major adverse cardiac events (cardiac death, myocardial
infarction, and clinically driven target vessel revascularization).
RESULTS Comparing the Angio-guided and FFR-guided groups, treatment of the SB (balloon or stenting) was
performed in 63.1% and 56.3% of lesions respectively (p ¼ 0.07); stenting of the SB was attempted in 38.1% and 25.9%,
respectively (p ¼ 0.01); and, when attempted, stenting was successful in 83.6% and 73.3% of SBs, respectively
(p ¼ 0.01). The 1-year composite major adverse cardiac event rate was 18.1% in both groups (hazard ratio: 0.91,
95% conﬁdence interval: 0.48 to 1.88; p ¼ 1.00). The 1-year target vessel revascularization and stent thrombosis rates
were 6.9% and 5.6% (p ¼ 0.82) and 1.3% and 0.6% (p ¼ 0.56) in the Angio-guided and FFR-guided groups,
respectively.
CONCLUSIONS In this multicenter, randomized trial, angiographic and FFR guidance of provisional SB stenting of true
coronary bifurcation lesions provided similar 1-year clinical outcomes. (Randomized Study on DK Crush Technique Versus
Provisional Stenting Technique for Coronary Artery Bifurcation Lesions; ChiCTR-TRC-07000015) (J Am Coll Cardiol Intv
2015;8:536–46) © 2015 by the American College of Cardiology Foundation.
AB BR E V I A T I O N S
AND ACRONYM S
Angio = angiography
DES = drug-eluting stent(s)
DMV = distal main vessel
DS = diameter of stenosis
FFR = fractional ﬂow reserve
KBI = kissing balloon inﬂation
MACE = major adverse
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537D espite improvements in devices and tech-nique, percutaneous coronary intervention(PCI) of true bifurcation lesions remains
challenging, with relatively unfavorable long-term
clinical outcomes after implanting drug-eluting
stents (DES) (1–9). Numerous studies have shown
that a provisional side-branch (SB) approach (with
balloon angioplasty in most cases when SB treatment
is needed) after main-vessel (MV) stenting results in
favorable outcomes for most bifurcations. Given theSEE PAGE 547
cardiac event(s)
MI = myocardial infarction
MV = main vessel
PCI = percutaneous
coronary intervention
QCA = quantitative
coronary angiography
SB = side branch
ST = stent thrombosis
TIMI = Thrombolysis In
Myocardial Infarction
TVR = target vessel
cularizationwell-described discordance between angiographic
severity and functional lesion signiﬁcance (10–12),
fractional ﬂow reserve (FFR)-guided SB stenting
might improve outcomes (13–15). However, SB
crossing with an FFR pressure wire may be techni-
cally challenging, and whether FFR-guided provi-
sional SB stenting is superior to angiography-guided
provisional SB stenting has never been evaluated.
Accordingly, we performed a randomized trial to
compare these 2 approaches with provisional SB
treatment in true coronary bifurcation lesions.
METHODS
The DKCRUSH-VI (Double Kissing Crush Versus Pro-
visional Stenting Technique for Treatment of Coro-
nary Bifurcation Lesions VI) study was conducted in
8 centers in China. The protocol was approved by the
ethics committee at each hospital, and all patients
provided written, informed consent.
INCLUSION AND EXCLUSION CRITERIA. Patients
18 years of age and older with silent ischemia, stable
or unstable angina with a single true coronary bifur-
cation lesion (Medina 1,1,1 or 0,1,1), diameter of ste-
nosis (DS) $50% in both the MV and SB, each with
a reference vessel diameter $2.5 to #4.0 mm were
included. The length of the MV and SB lesions had
to be completely covered by 2 stents, unless a
balloon- or stent-induced dissection necessitated a
third stent.From the *Nanjing First Hospital, Nanjing Medical University, Nanjing, China
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infarction (MI) within 1 month; left ventricu-
lar ejection fraction <30%; previous coronary
artery bypass graft surgery; target vessel
stenting or stroke within 6 months; a
distal left main coronary artery trifurcation
lesion with a nonrecanalized right coronary
artery chronic total occlusion; calciﬁcation
requiring rotational atherectomy; planned
surgery necessitating antiplatelet therapy
interruption within 6 months post-PCI; study
drug contraindication or intolerance; esti-
mated glomerular ﬁltration rate <40 ml/min/
1.73 m2 (Modiﬁcation of Diet in Renal Disease
formula); platelet count <10  109/l; liver
dysfunction; pregnancy; expected life span
<1 year; and inability to provide informed
consent.
RANDOMIZATION AND PROCEDURES. Patients
were randomly assigned in a 1:1 ratio to FFR-
guided or angiography (Angio)-guided SB
assessment and treatment. PCI was performed
exclusively with DES. In both groups, pre-dilating the
MV and SB before MV stenting was left to operator
discretion. The SB was wired in all patients, however,
before any MB dilations.
In the Angio group, after MV stenting, the SB was
dilated followed by kissing balloon inﬂation (KBI) if
any of the following criteria in the SB were present
(Figure 1): Thrombolysis In Myocardial Infarction
(TIMI) ﬂow grade <3, dissection greater than type A,
or ostial SB stenosis >70% (visually assessed). If any
of these criteria persisted after KBI, the SB was
recrossed through a distal MV stent cell, and SB
stenting was performed using the T-stenting and
small protrusion technique (TAP technique), fol-
lowed by ﬁnal KBI using noncompliant balloons at
$16 atm (9).
In the FFR group, after MV stenting, a pressure
wire was passed through a distal MV stent cell into
the SB and was used for all subsequent PCIs. KBI was
performed if the SB FFR was <0.80 (Figure 1), after
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FIGURE 1 Study Flowchart
True bifurcation lesions with SB ≥ 2.5 mm in diameter
FFR Group (N = 160) Angio Group (N = 160)
Stenting MV
SB-FFR<0.8 SB-DS ≥ 70%, Dissection, TIMI <3
Yes
Yes Yes
Yes
Follow-up
Stenting SB
FKBI
Stenting SB
FKBI
KBT KBT
No
A total of 320 patients were randomly assigned to angiography-guided or fractional ﬂow
reserve (FFR)–guided groups. DS ¼ diameter of stenosis; FKBI ¼ ﬁnal kissing balloon
inﬂation; KBT ¼ kissing balloon technique; MV ¼ main vessel; SB ¼ side branch;
TIMI ¼ Thrombolysis In Myocardial Infarction.
TABLE 1 Baseline Clinical Characteristics
Angio Group
(n ¼ 160)
FFR Group
(n ¼ 160) p Value
Age, yrs 65.4  9.2 65.2  9.6 0.85
Male 116 (72.5) 121 (75.6) 0.61
Height, cm 166.6  6.9 165.9  7.3 0.47
Weight, kg 68.4  10.1 67.5  10.9 0.48
Presentation
Unstable angina 99 (61.9) 98 (61.7) 0.98
Acute MI >1 month 25 (15.6) 28 (17.5) 0.64
STEMI 6 (3.8) 14 (8.8) 0.10
NSTEMI 19 (11.8) 14 (8.8) 0.67
Stable angina 36 (22.5) 34 (20.6) 0.63
Diabetes mellitus 43 (26.9) 48 (30.0) 0.62
Hypertension 106 (68.3) 116 (72.5) 0.28
Hyperlipidemia 32 (20.0) 27 (16.9) 0.56
Current smoker 64 (40.0) 66 (41.3) 0.91
Previous MI 19 (11.9) 12 (7.5) 0.26
Previous PCI 19 (11.9) 26 (16.3) 0.34
Previous CABG 0 (0) 1 (0.6) 0.50
Previous stroke 20 (12.5) 20 (12.5) 1.00
Peripheral artery disease 3 (1.9) 3 (1.9) 1.00
eGFR <60 ml/min/1.73 m2 32 (20.0) 28 (17.5) 0.67
Left ventricular ejection
fraction, %
60.6  8.7 61.3  7.4 0.54
Values are mean  SD or n (%).
Angio ¼ angiography; CABG ¼ coronary artery bypass graft; eGFR ¼ estimated
glomerular ﬁlter rate; FFR ¼ fractional ﬂow reserve; MI ¼ myocardial infarction;
NSTEMI ¼ non–ST-segment elevation myocardial infarction; PCI ¼ percutaneous
coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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538which FFR was remeasured. SB stenting (TAP tech-
nique) was performed only if the SB FFR was
still <0.80, followed by ﬁnal KBI using noncompliant
balloons at $16 atm (9).
The proximal optimal technique was used in all
cases in both groups. Intravascular ultrasound was
used at operator discretion. Anticoagulation was
achieved with unfractionated heparin (activated
clotting time 250 to 300 s), with glycoprotein IIb/IIIa
inhibitors selectively. A 300-mg pre-PCI clopidogrel
loading dose was administered if no long-term
clopidogrel use. Troponin I and creatine kinase-
myocardial band levels were measured 6 times
within 72 h post-procedure. Aspirin (100 mg/d) was
continued indeﬁnitely, and clopidogrel (75 mg/d)
for $12 months.
SB FFR MEASUREMENT. After 200 to 300 mg of
intracoronary nitroglycerin, the pressure wire trans-
ducer (Radi Medical Systems, Uppsala, Sweden) was
normalized to the guide catheter pressure in the aortaand then passed across the MV stent struts and
positioned $10 mm distal to the SB lesion. If the
pressure wire could not be passed into the SB, a
microcatheter over a conventional ﬂoppy wire in the
SB was used to exchange the pressure wire. If the
microcatheter could not enter the SB or diminished
ﬂow or greater than type B dissection was present,
the ostial SB was ﬁrst dilated with a 1.2-mm diameter
balloon. Hyperemia was induced by an intravenous
adenosine infusion (180 mg/kg/min). FFR <0.80 was
considered functionally signiﬁcant (10).
FOLLOW-UP. Clinical follow-up was performed at 1,
6, and 12 months. Routine angiographic follow-up
was scheduled at 13 months unless required
sooner. Follow-up FFR of the SB was performed in
the FFR-guided group. A clinical events committee
blinded to randomization adjudicated all adverse
events.
QUANTITATIVE CORONARY ANGIOGRAPHY. Angiograms
were analyzed ofﬂine using a validated automated
edge-detection coronary bifurcation system (CAAS
version 5.7, Pie Medical Imaging BV, Maastricht, the
TABLE 2 Lesion Characteristics
Angio Group
(n ¼ 160)
FFR Group
(n ¼ 160)
p
Value
Extent of disease 0.82
1 vessel 50 (31.3) 48 (30.2)
2 vessels 52 (32.5) 48 (30.2)
3 vessels 58 (36.3) 64 (39.6)
Bifurcation lesion site 0.69
Distal left main coronary artery 14 (8.8) 15 (9.4)
LAD diagonal 114 (71.3) 109 (68.2)
LCX obtuse marginal 23 (14.3) 29 (18.1)
RPLA-RPDA 9 (5.6) 7 (4.4)
Bifurcation pattern 0.30
Medina 1,1,1 139 (86.8) 132 (82.5)
Medina 0,1,1 21 (13.2) 28 (17.6)
Restenotic lesion
Main vessel 3 (1.9) 4 (2.5) 0.70
Side branch 2 (1.3) 0 0.50
Chronic total occlusion
Main vessel 13 (8.1) 14 (8.8) 0.84
Side branch 6 (3.8) 3 (1.9) 0.50
Thrombus-containing lesion
Main vessel 2 (1.3) 1 (0.6) 0.56
Side branch 0 (0.0) 1 (0.6) 0.50
Moderate to severe tortuosity
Main vessel 51 (31.9) 54 (33.8) 0.81
Side branch 79 (49.4) 77 (48.1) 0.91
Moderate to severe calciﬁcation
Main vessel 32 (20.0) 25 (15.6) 0.38
Side branch 12 (7.5) 4 (2.5) 0.07
TIMI ﬂow grade <3
Main vessel 21 (13.1) 20 (12.2) 0.54
Side branch 5 (3.1) 8 (5.0) 0.51
Values are n (%).
LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex artery; RPDA ¼
right posterior descending artery; RPLA ¼ right posterior lateral artery; TIMI ¼
Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.
TABLE 3 Procedural Characteristics
Angio Group
(n ¼ 160)
FFR Group
(n ¼ 160)
p
Value
Transradial access 148 (92.5) 150 (93.7) 0.36
Glycoprotein IIb/IIIa inhibitor 3 (1.9) 5 (3.1) 0.72
Pre-dilation
Main vessel 116 (72.5) 116 (72.5) 1.00
Side branch 11 (6.9) 3 (1.9) 0.06
After pre-dilation
Side-branch closure 7 (4.4) 5 (3.1) 0.65
Reopened 6 (85.7) 4 (80.0) 0.33
Kissing balloon inﬂation 101 (63.1) 90 (56.3) 0.07
Stenting of the side branch
Attempted 61 (38.1) 30 (25.9) 0.01
Implanted 51 (31.9) 22 (13.8) 0.01
Main vessel stent
n 1.56  0.73 1.56  0.72 1.00
Diameter, mm 2.98  0.34 3.00  0.36 0.49
Length, mm 43.0  22.8 43.7  21.9 0.81
Side-branch stent
n 0.97  0.31 0.13  0.34 <0.001
Diameter, mm 2.43  0.67 2.43  0.70 1.00
Length, mm 18.33  9.67 2.92  7.97 <0.001
Stent types 0.91
Xience V 57 (35.6) 64 (39.0)
Resolute 68 (42.5) 62 (37.8)
Firebird 35 (21.9) 38 (23.2)
Complete revascularization* 108 (68.4) 107 (67.7) 0.90
Angiographic success
Main vessel 160 (100.0) 159 (99.4) 1.00
Side branch 156 (97.5) 156 (97.5) 1.00
Procedural time, min 53.3  30.6 54.7  34.0 0.69
Fluoroscopy time, min 30.7  16.4 31.8  21.0 0.62
Contrast volume, ml 132.5  42.5 116.9  48.5 0.003
Values are n (%) or mean  SD. *Deﬁned as all lesions including lesions separate
from the index bifurcation.
Abbreviations as in Table 1.
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539Netherlands). Bifurcation lesions (9) were divided
into the proximal MV, distal MV (DMV), and SB
segments, each including 5-mm stent-adjacent mar-
gins. Measurements included reference vessel diam-
eter, minimal lumen diameter, DS, acute gain, and
late loss. Quantitative coronary angiography (QCA)
was performed by an independent core laboratory
(China Cardiovascular Research Foundation, Beijing,
China).
STUDY ENDPOINTS AND DEFINITIONS. The primary
endpoint was the 1-year rate of major adverse
cardiac events (MACE), the composite of cardiac
death, MI, or ischemia-driven target vessel revascu-
larization (TVR). Secondary endpoints included indi-
vidual MACE components, stent thrombosis (ST), and
restenosis.All deaths were considered cardiac in origin unless
noncardiac causes were certain. MI was deﬁned as a
creatine kinase-myocardial band increase to more
than 3 times the upper limit of normal in $2 samples
(16). ST was deﬁned according to the Academic
Research Consortium deﬁnite or probable criteria (17).
Angiographic success for the SB was deﬁned as TIMI
ﬂow grade 3 and for the MV as TIMI ﬂow grade 3
with QCA residual DS <20%. Procedural success was
deﬁned as angiographic success with no in-hospital
MACE. The pre-speciﬁed deﬁnition of angiographic
restenosis varied according to location and treatment
group. In both the Angio-guided and FFR-guided
groups, restenosis of the proximal MV, DMV, and
any stented SB was deﬁned as QCA DS >50%.
Restenosis in a nonstented SB was deﬁned as QCA
DS >70% in the Angio-guided group and as follow-up
FIGURE 2 Description of the Study Flow in the FFR-Guided Group
160 patients in FFR Group
Stenting MV
Measuring SB FFR
Successful (n = 145) Failed to measure (n = 15)
FFR <0.8
(n = 75,52%)
FFR ≥0.8
(n = 70,48%)
KBI
FFR ≥0.8FFR <0.8
(n = 26) (n = 49)
(n = 19)
(n = 1) (n = 3)
(n = 4) (n = 3) (n = 8)
(n = 7)
Failure Successfully
Successfully
Stenting SB
Failure
Stenting SB
FFR ≥0.8FFR <0.8 Failure
SB FFR
Dilating SB using 2.0-mm balloon
Failed to measure (n = 15)
SB FFR
Dilating SB using 1.2-mm balloon
SB FFR after MV stenting was successfully measured per protocol in 145 of 160 patients in
the FFR group. Of 15 patients (9.4%) in whom FFR could not be measured, FFR was ul-
timately measured in 12 patients after KBI using larger balloons. Thus, SB FFR could not be
measured in only 3 of 160 (1.9%) lesions. Abbreviations as in Figure 1.
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analysis, restenosis for all SB lesions was deﬁned as
QCA DS >50%.
STATISTICAL METHODOLOGY. Based on studies by
Koo et al. (15) and others (3–9), we estimated 1-year
MACE rates of 5% and 15% in the FFR-guided
and Angio-guided groups, respectively. Accordingly,
a sample size of 150 patients per group provided 80%
power to demonstrate superiority. Assuming 5% loss
to follow-up, recruitment of 160 patients per group
was planned.
Continuous variables are presented as mean 
SD and were compared using t or Mann-Whitneytest as appropriate. Categorical variables were
compared with the chi-square or Fisher exact test.
Event-free survival estimates were generated by
Kaplan-Meier methodology and compared using the
log-rank test. All tests are 2-sided, and p < 0.05
was considered signiﬁcant. All analyses were per-
formed with SPSS Version 16.0 (SPSS Inc., Chicago,
Illinois).
RESULTS
BASELINE CHARACTERISTICS. Between November
27, 2011 and June 25, 2013, 320 patients with true
coronary bifurcation lesions were randomized to
Angio guidance (n ¼ 160) or FFR guidance (n ¼ 160).
Baseline clinical and lesion characteristics were
well matched between groups (Tables 1 to 3).
Approximately 85% of bifurcation lesions were
Medina 1,1,1 and were most commonly left anterior
descending artery/diagonal bifurcations, although
notably w9% involved the distal left main coronary
artery.
PROCEDURAL CHARACTERISTICS. Pre-dilation of
the MV was performed in 72.5% of lesions in each
group, but was rarely performed in the SB (6.9% and
1.9% in the Angio-guided and FFR-guided groups,
respectively) before MV stenting. MV stenting was
successful in all 320 patients. Immediately after MV
stenting, 12 SBs (3.8%) (7 in the Angio-guided group
and 5 in the FFR-guided group) were acutely closed,
of which 10 (6 and 4, respectively) were successfully
reopened (Table 3).
FFR-GUIDED PROCEDURES. After MV stenting, FFR
measurement of the SB was achieved in 145 of 160
lesions (90.6%) and was <0.80 in 75 of 145 (52.0%).
After balloon dilation of these 75 lesions, the SB FFR
remained <0.80 in 26 (13.8%). Of the 15 of 160 lesions
(9.4%) in which SB FFR could not be measured
(despite KBI using a 1.2-mm SB balloon [Figure 2]),
FFR measurements were subsequently obtained in
12 lesions after larger balloon dilation; 4 had SB
FFR <0.80 and 8 had FFR $0.80. In total, FFR
remained <0.80 after balloon angioplasty in 30
lesions (18.8%), 22 of which (73.3%) had SB stents
successfully implanted.
ANGIO-GUIDED PROCEDURES. After MV stenting,
SB stents were required in 61 lesions (38.1%) after
balloon angioplasty because of dissection greater
than type A (n ¼ 11), TIMI ﬂow grade <3 (n ¼ 3), and
ostial SB stenosis >70% (n ¼ 47) (Figure 3). SB
stents were successfully deployed in 51 of 61 lesions
(83.6%).
FIGURE 3 Procedural Flowchart in the Angiography-Guided Group
160 patients in Angio Group
Stent MV
SB angiographic indications
Yes (n = 101, 63.1%)
KBI
Yes (n = 61,
60.4%)
No (n = 40, 39.6%)
>type A dissection
(n = 11) (n = 3)
TIMI flow <3
(n = 47)
SB DS > 70%
Stenting SB Stenting SB
Follow-up
No (n = 59, 36.9%)
Success (n = 11)
Failure (n = 0)
Success (n = 2)
Failure (n = 1)
Success (n = 39)
Failure (n = 8)
SB treatment after stenting MV was required in 63.1% of lesions. Finally, SB stents were
successfully implanted in 52 patients, with failure to deploy in 9 patients. Abbreviations as
in Figure 1.
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guided groups, any treatment of the SB (balloon or
stenting) was performed in 63.1% and 56.3% of
lesions, respectively (p ¼ 0.07); stenting of the SB
was attempted in 38.1% and 25.9%, respectively
(p ¼ 0.01), and stents were implanted in 31.9% and
13.8%, respectively (p ¼ 0.01).
CLINICAL FOLLOW-UP. In-hospital MI occurred in
12.5% and 11.9% of Angio-guided and FFR-guided
patients, respectively (p ¼ 0.86), mostly non–
Q-wave MIs. There were no in-hospital deaths, TVRs
or STs (Table 4).
One-year clinical follow-up was available for
100% of patients. The 1-year composite MACE
rate (primary endpoint) was 18.1% in both groups
(hazard ratio: 0.91, 95% conﬁdence interval: 0.48 to
1.88, p ¼ 1.00) (Table 4, Figure 4A), with the most
common event being MI (13.8% vs. 11.9%, p ¼ 0.74)
(Figure 4B). Deﬁnite/probable ST occurred in 1.3%
and 0.6% of patients in the Angio-guided and FFR-
guided groups, respectively (p ¼ 0.56), and TVR was
required in 6.9% and 5.6% patients, respectively
(p ¼ 0.82) (Figure 4C).
ANGIOGRAPHIC FOLLOW-UP. There were no signif-
icant QCA differences in the proximal MV between
the groups at follow-up (Table 5). However, late loss
was greater in the DMV in the Angio-guided group
(0.27  0.46 mm vs. 0.15  0.30 mm, p ¼ 0.02), as was
binary restenosis (9.9% vs. 1.7%, p ¼ 0.02). Specif-
ically, DMV restenosis was greatest in Angio-guided
lesions in which the SB was treated by either
balloon angioplasty or stenting rather than not
treated (Figure 5).
Regarding the SB, because fewer stents were
used for the SB in the FFR-guided group, in general,
the FFR group had less late loss but greater DS
(Table 6). In the FFR group, SB FFR <0.80 at
follow-up (FFR restenosis) was present in 4 un-
treated SBs (7.1%) and in 5 treated SBs (8.1%)
(p ¼ 0.84) (Figure 5). Using the post-hoc QCA deﬁ-
nition of any DS >50% in the SB, restenosis was
present in 14 (11.8%) versus 25 (21.2%) of SBs in the
Angio-guided and FFR-guided groups, respectively
(hazard ratio: 2.74, 95% conﬁdence interval: 1.99 to
4.02; p ¼ 0.04).DISCUSSION
The present study is the ﬁrst randomized trial
comparing FFR-guided and Angio-guided approaches
in true coronary bifurcation lesions in which provi-
sional SB stenting was intended. We found thefollowing. 1) Accessing the SB and obtaining SB FFR
measurements was feasible in 90.6% of cases and
compared with Angio-guidance resulted in fewer SB
PCIs, including fewer stents being implanted in the
SB. 2) Nonetheless, the 1-year rates of composite
MACE were identical (18.1%) with both FFR-guided
and Angio-guided provisional T stenting. 3) Angio-
graphic restenosis in the DMV and SB was slightly
more frequent with the Angio-guided approach,
although the differences were modest and did not
translate into differences in clinical event rates.
Angiography alone is most commonly used to
guide the decision whether and how to treat
SBs in coronary bifurcation lesions. However, the
FIGURE 4 Event-Free Survival During Follow-Up
(A) MACE-free survival. At 1-year after the index procedure, the MACE rate was 18.1% in
the 2 groups (p ¼ 1.00). (B) Myocardial infarction (MI)–free survival. At 1-year after the
index procedure, the MI rate was 13.8% in the Angio-guided group and 11.9% in the FFR-
guided group (p ¼ 0.62). (C) TVR-free survival. At 1-year after the index procedure, the
TVR rate was 6.9% in Angio-guided group and 5.6% in the FFR-guided group (p ¼ 0.65).
Angio ¼ angiography; CI ¼ conﬁdence interval; FFR ¼ fractional ﬂow reserve; MACE ¼
major adverse cardiac events; TVR ¼ target vessel revascularization.
TABLE 4 Clinical Outcomes
Angio Group
(n ¼ 160)
FFR Group
(n ¼ 160)
p
Value
In-hospital
Death 0 (0.0) 0 (0.0) —
Myocardial infarction 20 (12.5) 19 (11.9) 0.86
Q-wave 1 (0.6) 1 (0.6) 1.00
Non–Q-wave 19 (11.9) 18 (11.3) 0.86
Target lesion revascularization 0 (0.0) 0 (0.0) —
Target vessel revascularization 0 (0.0) 0 (0.0) —
Composite MACE 20 (12.5) 19 (11.9) 0.86
Stent thrombosis 0 (0.0) 0 (0.0) —
Procedural success 139 (86.9) 141 (88.1) 0.86
1-yr Kaplan-Meier rates
Death 2 (1.3) 3 (1.9) 0.65
Cardiac 1 (0.6) 2 (1.3) 0.56
Noncardiac 1 (0.6) 1 (0.6) 1.00
Myocardial infarction 22 (13.8) 19 (11.9) 0.74
Q-wave 1 (0.6) 1 (0.6) 1.00
Non–Q-wave 21 (13.1) 18 (11.3) 0.73
Target lesion revascularization 8 (5.0) 5 (3.1) 0.57
Target vessel revascularization 11 (6.9) 9 (5.6) 0.82
Coronary artery bypass
graft surgery
0 (0.0) 0 (0.0) —
Composite MACE
(primary endpoint)
29 (18.1) 29 (18.1) 1.00
Stent thrombosis 2 (1.3) 1 (0.6) 0.56
Deﬁnite 1 (0.6) 1 (0.6) 1.00
Probable 1 (0.6) 0 (0.0) 0.50
Values are n (%).
MACE ¼ major adverse cardiac event(s); other abbreviations as in Table 1.
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542discrepancy between angiographic DS and FFR (with
angiography often leading to overtreatment of non–
ﬂow-limiting lesions) suggests that outcomes might
be improved by physiological assessment. In this
regard, FFR has become the gold standard for
assessing the functional signiﬁcance of a coronary
lesion (10,18–20). The FAME (Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation)
(10,20) and DEFER (19) studies demonstrated en-
hanced event-free survival after FFR-guided com-
pared with Angio-guided PCI in nonbifurcation
lesions, with fewer stents used and reduced cost.
Because most SBs supply only a moderate amount
of myocardium, an FFR-guided provisional stent
strategy may be particularly desirable, obviating
stenting in many cases.
In addition, after MV stent implantation, ostial
SB lesions frequently appear angiographically more
severe due to dissection, spasm, thrombus, metal
strut protrusion, and/or most commonly plaque or
carina shift (2,21). Similar to nonbifurcation lesions,
discordance is often present between angiographic
DS and FFR in SBs after MV stenting (11–13,15,22–26).
TABLE 5 Quantitative Coronary Analysis in Main Vessel
Angio Group
(n ¼ 119)
FFR Group
(n ¼ 118)
p
Value
Bifurcation angle 48.8  18.8 52.5  20.4 0.59
Lesion length, mm 31.0  19.3 30.5  15.5 0.82
Proximal main vessel
RVD, mm
Baseline 2.94  0.41 2.92  0.41 0.69
Post-stenting 3.24  0.39 3.14  0.44 0.047
Follow-up 3.21  0.38 3.11  0.45 0.06
MLD, mm
Baseline 1.18  0.33 1.19  0.35 0.42
Post-stenting 2.94  0.41 2.88  0.47 0.45
Acute gain 1.76  0.47 1.70  0.45 0.49
Follow-up 2.79  0.54 2.68  0.59 0.14
Late loss 0.15  0.37 0.14  0.36 0.92
Diameter stenosis, %
Baseline 55.4  5.3 56.1  7.4 0.45
Post-stenting 9.4  6.4 10.1  6.7 0.46
Follow-up 13.2  2.9 14.3  2.1 0.54
Binary restenosis*
In-stent 0 (0.0) 0 (0.0) —
In-segment 4 (3.4) 2 (1.7) 0.68
Distal main vessel
RVD, mm
Baseline 2.46  0.36 2.48  0.35 0.66
Post-stenting 2.70  0.33 2.68  0.36 0.54
Follow-up 2.65  0.33 2.64  0.37 0.83
MLD, mm
Baseline 1.10  0.41 1.14  0.49 0.64
Post-stenting 2.37  0.36 2.36  0.41 0.82
Acute gain 1.27  0.56 1.22  0.55 0.53
Follow-up 2.11  0.56 2.21  0.53 0.13
Late loss 0.27  0.46 0.15  0.30 0.02
Diameter stenosis, %
Baseline 55.9  2.3 54.6  2.2 0.67
Post-stenting 12.3  7.8 12.0  6.8 0.78
Follow-up 20.1  18.2 17.9  13.2 0.052
Binary restenosis*
In-stent 9 (7.6) 1 (0.9) 0.03
In-segment 11 (9.2) 2 (1.7) 0.01
Values are mean  SD or n (%). *According to the protocol deﬁnition.
MLD ¼ minimal lumen diameter; RVD ¼ reference vessel, diameter; other
abbreviations as in Table 1.
FIGURE 5 Distribution of Restenosis 13 Months After Stenting
Different deﬁnitions of restenosis were used in this study (see the Methods section
for details). SBs were classiﬁed as treated (dilated or stented) and not treated (neither
dilated nor stented). Restenosis was more frequent in the DMV in the treated SB subgroup
in patients assigned to Angio-guidance (14.1%) than in the other 3 subgroups. FFR
restenosis was present in 7.1% of the not treated SB subgroup in the FFR-guided group.
DMV ¼ distal main vessel; PMV ¼ proximal main vessel; other abbreviations as in
Figures 1 and 4.
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543Koo et al. (15) found that only 27% of SBs with an-
giographic DS >75% had FFR <0.75, and no SB
lesion with angiographic DS <75% had functionally
signiﬁcant FFR. Conversely, after MV stenting in the
DKCRUSH-IV study (13), FFR was <0.80 in 12% of
angiographic nonsigniﬁcant SB lesions, an observa-
tion conﬁrmed by Ahn et al. (22). In the present study,
FFR was <0.80 in 52% of 145 lesions after MV stent-
ing. FFR was positive in an additional 4 of 12 cases in
which PCI with a 2.0-mm balloon was required to
facilitate FFR wire-crossing. The higher rate offunctionally signiﬁcant SB stenoses in the present
trial compared with past studies is most likely due to
differences in Medina classiﬁcation, vessel size, and
lesion length of the bifurcation lesions in these
studies.
Previous studies have demonstrated that an an-
giographically guided provisional SB approach (with
stenting reserved for severe DS, dissection, and/or
TIMI ﬂow grade <3) is effective for most coronary
bifurcation lesions (3–9). However, the angiographic
triggers prompting SB stenting have varied in these
studies, and the optimal angiographic criteria are
uncertain. Conversely, there are few data regarding
outcomes after FFR-guided provisional bifurcation
stenting. In the nonrandomized study by Koo et al.
(15), stenting of 20 of 97 SBs with FFR <0.75
after MV stenting was associated with fewer MACE
than in an Angio-guided historical control popula-
tion (4.6% vs. 13.0%) (3–9). In the present ran-
domized trial, although FFR-guided SB assessment
resulted in somewhat less SB intervention and
fewer stents being implanted, the 1-year rate of
composite MACE was identical to that with the
simpler Angio-guided approach, with similar rates
of TVR and ST.
Passing the pressure wire through MV stent struts
into the SB may be challenging. Ahn et al. (21)
reported that SB FFR could not be measured in 11 of
241 cases (4.6%) after MV stenting, due to failure
TABLE 6 Quantitative Coronary Analysis in Side Branch
Angio Group
(n ¼ 119)
FFR Group
(n ¼ 118)
p
Value
Lesion length, baseline, mm 12.8  8.4 11.9  8.7 0.39
RVD, mm
Baseline 2.28  0.29 2.23  0.30 0.21
Post-procedure 2.43  0.28 2.18  0.30 <0.001
Follow-up 2.39  0.33 2.15  0.29 <0.001
MLD, mm
Baseline 1.10  0.49 1.18  0.51 0.25
Post-procedure 2.05  0.44 1.45  0.47 <0.001
Acute gain 0.95  0.55 0.27  0.61 <0.001
Follow-up 1.79  0.64 1.38  0.49 <0.001
Late loss 0.27  0.49 0.07  0.39 0.001
Diameter stenosis, %
Baseline 57.8  3.9 57.6  4.4 0.08
Post-procedure 16.1  13.6 33.6  18.2 <0.001
Follow-up 25.9  22.9 36.1  20.1 <0.001
Binary restenosis* 14 (11.8) 25 (21.2) 0.04
Values are mean  SD or n (%). *According to the protocol deﬁnition.
Abbreviations as in Table 5.
Chen et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 4 , 2 0 1 5
FFR- vs. Angiography-Guided Provisional Stenting A P R I L 2 0 , 2 0 1 5 : 5 3 6 – 4 6
544to pass the pressure wire (n ¼ 7) and wire-induced
SB dissection (n ¼ 4). Similarly, the FFR SB access
failure rate in the current multicenter study was
9.4%, although it decreased to 1.9% after KBI using
2.0-mm diameter balloons. Additionally, we were
unable to pass stents in 18 of 91 SBs (19.8%). These
observations demonstrate that provisional SB stent-
ing is technically demanding, warranting continued
development of dedicated bifurcation stents and
strategies.
Because of the small amount of myocardium sup-
plied, many SB lesions are not functionally signiﬁ-
cant, and MV rather than SB restenosis is responsible
for most TVRs (3–9). Consequently, technique opti-
mization should be directed at ensuring freedom from
MV restenosis while keeping the SB patent. However,
we found that almost all SB restenotic lesions
extended into the DMV, and as such, the higher SB
restenosis rate in the Angio-guided group contributed
to greater late loss and restenosis in the DMV in these
patients. This ﬁnding may be explained by protrusion
of SB struts into the DMV, especially if the bifurcation
angle is narrow and KBI is suboptimal (27,28).
Abnormal shear stress at the ostial SB and DMV may
also be involved (29).
CLINICAL IMPLICATIONS. Given the nearly identical
1-year MACE rates with both approaches, either the
Angio-guided or FFR-guided technique may be rec-
ommended for provisional SB stenting of truecoronary bifurcation lesions. The FFR-guided tech-
nique may result in somewhat fewer stents being
implanted and a slightly lower long-term restenosis
rate, but is technically challenging and requires
the upfront cost of a pressure wire in all patients.
Formal cost accounting was not performed in this
study.
STUDY LIMITATIONS. FFR <0.80 was somewhat
arbitrarily chosen to deﬁne functional signiﬁcance,
Although the results would likely have been similar
with a different threshold, we cannot exclude slight
differences. Although MACE rates were higher than
the sample size estimates, the present study cannot
exclude small clinical outcome differences between
the 2 approaches. Moreover, the absence of any SB
treatment inw40% of cases further lessens the ability
to show differences between the groups. However,
only Medina 1,1,1 and 0,1,1 bifurcations were included
in the present study, and the low follow-up event
rates suggest that a provisional single-stent approach
is appropriate for many such lesions. Operators
were necessarily unblinded, which may have intro-
duced bias and inﬂuenced procedural decisions
(e.g., whether to pre-dilate, total ﬂuoroscopy time).
Finally, the optimal stent technique and role of
dedicated devices in highly complex bifurcations
deserves further study.CONCLUSIONS
Based on the results of the current multicenter ran-
domized trial, FFR-guided and Angio-guided provi-
sional SB stenting of true coronary bifurcation
lesions are associated with similar 1-year MACE
rates.
ACKNOWLEDGMENTS The authors thank Lin Ling,
Yin-Yin Zhao, Ling-Ling Liu, and Jing Kan, for their
contributions to data collection and monitoring. They
also acknowledge Professors Bao-Xiang Duan and
Ming-Fan Zha, Directors of the Independent Mem-
bers, for analyzing clinical events.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Shao-Liang Chen, Cardiology Department, Nanjing
First Hospital, 68 Changle Road, Nanjing 210006,
China. E-mail: chmengx@126.com. OR Dr. Gregg W.
Stone, Columbia University Medical Center, The
Cardiovascular Research Foundation, 111 East 59th
Street, 11th Floor, New York, New York 10022. E-mail:
gstone@crf.org.
PERSPECTIVES
FFR is the gold standard for the assessment of the func-
tional signiﬁcance of lesions in the coronary artery, and
FFR-guided implantation of a DES for either stable or un-
stable coronary artery disease is reported to be associated
with less frequent clinically worse events. However, FFR-
guided DES implantation for coronary bifurcation lesions
has not been assessed by a randomized, multicenter study.
Moreover, a provisional SB stenting technique guided by
angiography is effective for a great majority of bifurcation
lesions. Accordingly, this study was designed to compare
the difference in 1-year MACE rate between FFR-guided
and angiography-guided provisional SB stenting for bifur-
cation lesions deﬁned asMedina 1,1, and0,1,1 lesionswith a
minimal SB diameter of 2.5mm.Our results showed that an
FFR-guided procedure had the same 1-year MACE rate as
the angiography-guided procedure. Interestingly, we
also found that the failure rate of deploying a DES in SB
in the 2 groups was not low, indicating the limitation
of provisional stenting for more complex bifurcation
lesions. Additionally, measuring SB FFR after MV stent-
ing was not successful in almost 9% of SBs, suggesting
the disadvantage of the FFR-guided procedure for
anatomically complex SB lesions. As a result, coronary
bifurcation lesions should be stratiﬁed according to
lesion complexity, and further clinical trials are required
to determine the superiority of FFR-guided provisional
stenting over the anatomy-oriented provisional SB
stenting technique.
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